The Vitamin Shoppe enters South Korea
Premium
3 August 2021
The Vitamin Shoppe has entered South Korea through an e-commerce website and online marketplaces.
Industry News
You can read our Premium News Service in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.
The Vitamin Shoppe enters South Korea
VMS acquisitions boost Nestlé Health Science
Premium
2 August 2021
Nestlé Health Science reported sales up by 24.3% to CHF1.91 billion (USD2.11 billion) in the first half of 2021, following a series of acquisitions involving vitamins, minerals and supplements (VMS) assets.
Nestlé talks about its international VMS plans
Premium
2 August 2021
Nestlé’s vitamins, minerals and supplements (VMS) brands have “very strong global appeal”, says chief executive officer Mark Schneider, adding there is “significant inbound interest from all four corners of the world to do more with that”.
P&G promotes Moeller to chief executive officer
Premium
30 July 2021
Procter & Gamble (P&G) has announced that its chief operating officer Jon Moeller will take over as president and chief executive officer with effect from 1 November 2021.
Sanofi India to divest nutraceuticals business
Premium
30 July 2021
Sanofi India is divesting its nutraceuticals business – including the Seacod and E-Cod cod liver oil brands – to Universal Nutriscience in a deal worth INR5.87 billion (USD0.08 billion) including debt.
Sanofi and Stada strike major distribution deal
Premium
28 July 2021
Sanofi is handing over distribution and marketing of around 50 consumer healthcare brands in 20 European countries to Germany’s Stada.
Reckitt’s OTC sales down but future looks brighter
Premium
28 July 2021
Worldwide sales of Reckitt’s OTC brands fell by more than 30% in the first half of 2021, but the company said trends had “improved as the second quarter progressed” and “retailer stocks are now at more normal levels”.
Reckitt’s VMS sales fall despite Neuriva rise
Premium
28 July 2021
Worldwide sales of Reckitt’s vitamins, minerals and supplements (VMS) portfolio fell by 15% in the first half of 2021 as Neuriva recorded “exceptionally strong growth” but Airborne struggled in the “weak cold and flu season”.
GSK appoints McNamara to lead standalone business
23 July 2021
GlaxoSmithKline (GSK) has announced that Brian McNamara will remain chief executive officer of its Consumer Healthcare business following the planned separation in 2022.
J&J anticipates a more normal second half
Premium
23 July 2021
Johnson & Johnson (J&J) expects to see “more normalised growth” in the second half of 2021 as “consumers return to typical usage patterns”.